GLEMSER TECHNOLOGIES EUROPE LIMITED

Glemser Technologies Europe Limited is a specialist provider of AI‑driven, structured‑content solutions for the life‑sciences sector. Its flagship ComplianceAuthor AI® platform acts as an authoring assistant, enabling global pharmaceutical teams to create, manage and deploy regulatory documentation—from product labels and clinical labelling to CMC dossiers and translation packs—within a single, secure environment. By training the AI on a company’s existing regulatory content, Glemser automates repetitive tasks, re‑uses compliant components across multiple outputs and delivers submission‑ready files in roughly half the time traditionally required.

Key services include AI‑enhanced authoring, component‑based content reuse, and end‑to‑end workflow optimisation, all built on a life‑sciences language model that recognises relevant regulations and extracts data automatically. Clients report up to a 50 % reduction in labelling timelines, 30 % cost savings and markedly improved quality and compliance. Glemser’s approach is trusted by large multinational pharma organisations, who value the blend of technical expertise, change‑management support and responsive, on‑demand assistance that the company brings to every project.